Trade Merck KGaA - EUR - MRKd CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.35 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.019349% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.002873% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Germany | ||||||||
| Commission on trade | 0% |
| Prev. Close | 143.05 |
| Open | 143.35 |
| 1-Year Change | -1.85% |
| Day's Range | 141.35 - 144.3 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 16, 2025 | 143.05 | 2.75 | 1.96% | 140.30 | 143.40 | 140.30 |
| Jan 15, 2025 | 141.65 | 1.80 | 1.29% | 139.85 | 143.10 | 139.85 |
| Jan 14, 2025 | 140.50 | -0.80 | -0.57% | 141.30 | 145.40 | 140.20 |
| Jan 13, 2025 | 140.70 | -0.70 | -0.50% | 141.40 | 142.00 | 140.35 |
| Jan 10, 2025 | 142.15 | 0.85 | 0.60% | 141.30 | 143.00 | 141.00 |
| Jan 9, 2025 | 141.75 | -1.05 | -0.74% | 142.80 | 143.50 | 140.65 |
| Jan 8, 2025 | 142.80 | -1.95 | -1.35% | 144.75 | 145.30 | 142.10 |
| Jan 7, 2025 | 145.25 | 3.00 | 2.11% | 142.25 | 145.90 | 142.25 |
| Jan 6, 2025 | 143.15 | 3.55 | 2.54% | 139.60 | 143.30 | 139.60 |
| Jan 3, 2025 | 140.30 | 0.10 | 0.07% | 140.20 | 141.30 | 139.35 |
| Jan 2, 2025 | 140.25 | 2.10 | 1.52% | 138.15 | 140.30 | 138.15 |
| Dec 30, 2024 | 138.95 | -0.35 | -0.25% | 139.30 | 139.60 | 138.65 |
| Dec 27, 2024 | 139.45 | 1.25 | 0.90% | 138.20 | 139.60 | 138.05 |
| Dec 23, 2024 | 138.00 | 1.20 | 0.88% | 136.80 | 138.80 | 136.70 |
| Dec 20, 2024 | 137.90 | 0.35 | 0.25% | 137.55 | 138.00 | 135.55 |
| Dec 19, 2024 | 138.20 | -1.15 | -0.83% | 139.35 | 140.15 | 137.55 |
| Dec 18, 2024 | 140.40 | 0.90 | 0.65% | 139.50 | 140.45 | 139.05 |
| Dec 17, 2024 | 139.35 | -0.15 | -0.11% | 139.50 | 141.60 | 139.25 |
| Dec 16, 2024 | 140.40 | -0.10 | -0.07% | 140.50 | 141.15 | 139.15 |
| Dec 13, 2024 | 140.85 | -1.40 | -0.98% | 142.25 | 142.75 | 140.80 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Merck - EUR Company profile
About Merck KGaA
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Merck KGaA revenues increased 12% to EUR19.69B. Net income applicable to common stockholders increased 54% to EUR3.06B. Revenues reflect Life Science segment increase of 20% to EUR8.99B, Healthcare segment increase of 7% to EUR7.09B, United States (Country) segment increase of 13% to EUR5.25B, Rest of Europe segment increase of 14% to EUR4.03B.
Equity composition
2003 Q1 has been restated to reflect discontinued operations. 01/2007, Rights Issue, 4 new shares for every 29 shares held @ EUR 78 (Factor: 1.015602). 6/2014, 2-for-1 stock split (Factor: 2).
| Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com